BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0593-2018

Bella All Natural · Los Angeles, CA

Class I — life-threatening Terminated 348 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015

Lot / code: Lot #: MFD:10.15.2017, Exp.10/14/2019.

Quantity: 32 bottles

Reason for recall

Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.

Recall record

Recall number
D-0593-2018
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Product was distributed in California to online customers and retail stores.
Recall initiated
2018-02-14
Classified by FDA Center
2018-03-13
FDA published
2018-03-14
Terminated
2019-01-28
Recalling firm
Bella All Natural
Firm location
Los Angeles, CA

‹ All recalls